Cargando…
Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial
INTRODUCTION: Gout is a painful form of inflammatory arthritis associated with several comorbidities, particularly cardiovascular disease. Cherries, which are rich in anti-inflammatory and antioxidative bioactive compounds, are proposed to be efficacious in preventing and treating gout, but recommen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073821/ https://www.ncbi.nlm.nih.gov/pubmed/32179562 http://dx.doi.org/10.1136/bmjopen-2019-035108 |
_version_ | 1783506706238537728 |
---|---|
author | Lamb, Kirstie Louise Lynn, Anthony Russell, Jean Barker, Margo E |
author_facet | Lamb, Kirstie Louise Lynn, Anthony Russell, Jean Barker, Margo E |
author_sort | Lamb, Kirstie Louise |
collection | PubMed |
description | INTRODUCTION: Gout is a painful form of inflammatory arthritis associated with several comorbidities, particularly cardiovascular disease. Cherries, which are rich in anti-inflammatory and antioxidative bioactive compounds, are proposed to be efficacious in preventing and treating gout, but recommendations to patients are conflicting. Cherry consumption has been demonstrated to lower serum urate levels and inflammation in several small studies. One observational case cross-over study reported that cherry consumption was associated with reduced risk of recurrent gout attacks. This preliminary evidence requires substantiation. The proposed randomised clinical trial aims to test the effect of consumption of tart cherry juice on risk of gout attacks. METHODS AND ANALYSIS: This 12-month, parallel, double-blind, randomised, placebo-controlled trial will recruit 120 individuals (aged 18–80 years) with a clinical diagnosis of gout who have self-reported a gout flare in the previous year. Participants will be randomly assigned to an intervention group, which will receive Montmorency tart cherry juice daily for a 12-month period, or a corresponding placebo group, which will receive a cherry-flavoured placebo drink. The primary study outcome is change in frequency of self-reported gout attacks. Secondary outcome measures include attack intensity, serum urate concentration, fractional excretion of uric acid, biomarkers of inflammation, blood lipids and other markers of cardiovascular risk. Other secondary outcome measures will be changes in physical activity and functional status. Statistical analysis will be conducted on an intention-to-treat basis. ETHICS AND DISSEMINATION: This study has been granted ethical approval by the National Research Ethics Service, Yorkshire and The Humber—Leeds West Research Ethics Committee (ref: 18/SW/0262). Results of the trial will be submitted for publication in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT03621215. |
format | Online Article Text |
id | pubmed-7073821 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-70738212020-03-20 Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial Lamb, Kirstie Louise Lynn, Anthony Russell, Jean Barker, Margo E BMJ Open Rheumatology INTRODUCTION: Gout is a painful form of inflammatory arthritis associated with several comorbidities, particularly cardiovascular disease. Cherries, which are rich in anti-inflammatory and antioxidative bioactive compounds, are proposed to be efficacious in preventing and treating gout, but recommendations to patients are conflicting. Cherry consumption has been demonstrated to lower serum urate levels and inflammation in several small studies. One observational case cross-over study reported that cherry consumption was associated with reduced risk of recurrent gout attacks. This preliminary evidence requires substantiation. The proposed randomised clinical trial aims to test the effect of consumption of tart cherry juice on risk of gout attacks. METHODS AND ANALYSIS: This 12-month, parallel, double-blind, randomised, placebo-controlled trial will recruit 120 individuals (aged 18–80 years) with a clinical diagnosis of gout who have self-reported a gout flare in the previous year. Participants will be randomly assigned to an intervention group, which will receive Montmorency tart cherry juice daily for a 12-month period, or a corresponding placebo group, which will receive a cherry-flavoured placebo drink. The primary study outcome is change in frequency of self-reported gout attacks. Secondary outcome measures include attack intensity, serum urate concentration, fractional excretion of uric acid, biomarkers of inflammation, blood lipids and other markers of cardiovascular risk. Other secondary outcome measures will be changes in physical activity and functional status. Statistical analysis will be conducted on an intention-to-treat basis. ETHICS AND DISSEMINATION: This study has been granted ethical approval by the National Research Ethics Service, Yorkshire and The Humber—Leeds West Research Ethics Committee (ref: 18/SW/0262). Results of the trial will be submitted for publication in a peer-reviewed journal. TRIAL REGISTRATION NUMBER: NCT03621215. BMJ Publishing Group 2020-03-15 /pmc/articles/PMC7073821/ /pubmed/32179562 http://dx.doi.org/10.1136/bmjopen-2019-035108 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Rheumatology Lamb, Kirstie Louise Lynn, Anthony Russell, Jean Barker, Margo E Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title | Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title_full | Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title_fullStr | Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title_full_unstemmed | Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title_short | Effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
title_sort | effect of tart cherry juice on risk of gout attacks: protocol for a randomised controlled trial |
topic | Rheumatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073821/ https://www.ncbi.nlm.nih.gov/pubmed/32179562 http://dx.doi.org/10.1136/bmjopen-2019-035108 |
work_keys_str_mv | AT lambkirstielouise effectoftartcherryjuiceonriskofgoutattacksprotocolforarandomisedcontrolledtrial AT lynnanthony effectoftartcherryjuiceonriskofgoutattacksprotocolforarandomisedcontrolledtrial AT russelljean effectoftartcherryjuiceonriskofgoutattacksprotocolforarandomisedcontrolledtrial AT barkermargoe effectoftartcherryjuiceonriskofgoutattacksprotocolforarandomisedcontrolledtrial |